NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $282 | -99.3% | 17,900 | +59.8% | 0.02% | +700.0% |
Q3 2022 | $38,000 | -80.4% | 11,200 | -0.9% | 0.00% | -78.6% |
Q2 2022 | $194,000 | +234.5% | 11,304 | -44.9% | 0.01% | +366.7% |
Q1 2022 | $58,000 | -12.1% | 20,500 | +259.6% | 0.00% | -25.0% |
Q4 2019 | $66,000 | -59.8% | 5,700 | -14.9% | 0.00% | -73.3% |
Q3 2019 | $164,000 | +164.5% | 6,700 | -33.7% | 0.02% | +150.0% |
Q2 2019 | $62,000 | -81.6% | 10,100 | -21.7% | 0.01% | -82.9% |
Q1 2019 | $337,000 | -2.3% | 12,900 | +57.3% | 0.04% | +6.1% |
Q4 2018 | $345,000 | +146.4% | 8,200 | -29.3% | 0.03% | +230.0% |
Q3 2018 | $140,000 | +211.1% | 11,600 | -4.9% | 0.01% | +400.0% |
Q2 2017 | $45,000 | +275.0% | 12,200 | +312.9% | 0.00% | – |
Q1 2017 | $12,000 | – | 2,955 | +23.1% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 2,400 | -59.3% | 0.00% | – |
Q3 2016 | $5,000 | -95.9% | 5,900 | -7.2% | 0.00% | -100.0% |
Q2 2016 | $121,000 | +44.0% | 6,355 | +12.4% | 0.01% | 0.0% |
Q1 2016 | $84,000 | -89.5% | 5,655 | -72.5% | 0.01% | -86.7% |
Q4 2015 | $797,000 | – | 20,542 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |